Dr. Roe's group cautioned about extrapolating the results to patient populations other than NSTEMI. They also noted that the study was limited by lack of information on awareness of physicians about the ESC data and other scientific developments and other factors that may have influenced decision-making, such as perception of the long-term bleeding risks.